Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (241-250 of 333) with videos related to

Pageof 34
Sort By:
BMC Cancer|April 3, 2026
Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort studyAlejandro Avilés-Salas, David Dávila Dupont, Alejandro Aranda-Gutierrez, et al.
Frontiers in Oncology|January 24, 2022
Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and NivolumabRemberto Burgos, Andrés F Cardona, Nicolas Santoyo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2026
Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysisLuis Cabrera-Miranda, Federico Maldonado, Eduardo Rios-Garcia, et al.
Anticancer Research|October 25, 2017
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus BevacizumabBeatriz Wills, Andrés F Cardona, Leonardo Rojas, et al.
Diabetologia|September 7, 2006
Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectinJ M Fernández-Real, M Straczkowski, J Vendrell, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 29, 2020
From discourse to pathology: Automatic identification of Parkinson's disease patients via morphological measures across three languagesElif Eyigoz, Melody Courson, Lucas Sedeño, et al.
Vaccine|September 11, 2021
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)Heather L Platt, Jose F Cardona, Miwa Haranaka, et al.
Frontiers in Oncology|May 7, 2021
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural MesotheliomaOscar Arrieta, Wendy Muñoz-Montaño, Sae Muñiz-Hernández, et al.
Lancet (London, England)|November 11, 2025
Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trialHiddo J L Heerspink, José F Cardona, Shivinder Jolly, et al.
Journal of Pathology Informatics|July 2, 2026
Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancerJorge Luis Rodríguez, Eduard Rodríguez, Richard Gil, et al.
Pageof 34

Showing results (241-250 of 333) with videos related to

Sort By:
Pageof 34
BMC Cancer|April 3, 2026
Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort studyAlejandro Avilés-Salas, David Dávila Dupont, Alejandro Aranda-Gutierrez, et al.
Frontiers in Oncology|January 24, 2022
Case Report: Differential Genomics and Evolution of a Meningeal Melanoma Treated With Ipilimumab and NivolumabRemberto Burgos, Andrés F Cardona, Nicolas Santoyo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2026
Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysisLuis Cabrera-Miranda, Federico Maldonado, Eduardo Rios-Garcia, et al.
Anticancer Research|October 25, 2017
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus BevacizumabBeatriz Wills, Andrés F Cardona, Leonardo Rojas, et al.
Diabetologia|September 7, 2006
Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectinJ M Fernández-Real, M Straczkowski, J Vendrell, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|September 29, 2020
From discourse to pathology: Automatic identification of Parkinson's disease patients via morphological measures across three languagesElif Eyigoz, Melody Courson, Lucas Sedeño, et al.
Vaccine|September 11, 2021
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)Heather L Platt, Jose F Cardona, Miwa Haranaka, et al.
Frontiers in Oncology|May 7, 2021
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural MesotheliomaOscar Arrieta, Wendy Muñoz-Montaño, Sae Muñiz-Hernández, et al.
Lancet (London, England)|November 11, 2025
Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trialHiddo J L Heerspink, José F Cardona, Shivinder Jolly, et al.
Journal of Pathology Informatics|July 2, 2026
Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancerJorge Luis Rodríguez, Eduard Rodríguez, Richard Gil, et al.
Pageof 34